The use of recombinant human epidermal growth factor(rh-EGF, Nepidermin) to minimize scar formation

• ISSUE 2010
• CATEGORY Wound
• PRODUCT Easyef Ointment
• UPDATE 2017.08.29

The effect of various concentrations of human recombinant epidermal growth factor on split-thickness skin wounds

• ISSUE 2006
• CATEGORY Wound
• PRODUCT Easyef Ointment
• UPDATE 2017.08.29

A comparative study of CGCryoDerm and AlloDerm in direct-to-implant immediate breast reconstruction

• ISSUE 2013
• CATEGORY Wound
• PRODUCT CGderm™
• UPDATE 2017.08.29

Efficacy of negative pressure therapy to enhance take of 1-stage allodermis and a split-thickness graft

• ISSUE 2007
• CATEGORY Wound
• PRODUCT CGderm™
• UPDATE 2017.08.29

One stage allogenic acellular dermal matrices (ADM) and split-thickness skin graft with negative pressure wound therapy

• ISSUE 2013
• CATEGORY Wound
• PRODUCT CGderm™, Curasys™, CureVAC®
• UPDATE 2017.08.29

Comparison of negative pressure wound therapy and secondary intention healing after excision of acral lentiginous melanoma on the foot

• ISSUE 2013
• CATEGORY Wound
• PRODUCT CureVAC®
• UPDATE 2017.08.29

Treatment of a chronic gouty ulcer on the lateral malleolus with vacuum-assisted closure (VAC) therapy

• ISSUE 2012
• CATEGORY Wound
• PRODUCT CureVAC®
• UPDATE 2017.08.29

Acute postpneumonectomy empyema with bronchopleural fistula treated with vacuum-assisted closure device

• ISSUE 2012
• CATEGORY Wound
• PRODUCT CureVAC®
• UPDATE 2017.08.29

Negative-pressure wound therapy using modified vacuum-assisted closure in patients with diabetic foot ulcers

• ISSUE 2011
• CATEGORY Wound
• PRODUCT CureVAC®
• UPDATE 2017.08.29

Efficacy of Curavac® system to enhance skin graft survival in chronic intractable wound

• ISSUE 2010
• CATEGORY Wound
• PRODUCT CureVAC®
• UPDATE 2017.08.29